BioLegend

BioLegend is a biotechnology company focused on the development and manufacture of antibodies, recombinant proteins, cell analysis kits, and other reagents for biomedical research. Based in San Diego, California, BioLegend's products are primarily used in immunology, cell biology, cancer research, neuroscience, and stem cell research.

The company was founded in 2002. Its initial focus was on providing high-quality antibodies for leukocyte cell surface markers. Over time, BioLegend has expanded its product portfolio to include reagents for a wide range of research applications, covering diverse areas of biology.

BioLegend's products are sold directly to researchers and through distributors worldwide. The company emphasizes rigorous quality control and validation processes in the production of its reagents, aiming to provide reliable and reproducible results for scientific research.

In 2021, BioLegend was acquired by PerkinElmer, Inc. As a part of PerkinElmer, BioLegend continues to operate as a distinct business unit.